Results 151 to 160 of about 28,042 (215)

Sodium zirconium cyclosilicate in HFrEF and hyperkalemia: REALIZE-K design and baseline characteristics

open access: yes
Background: Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF). However, MRAs are often underused because of hyperkalemia concerns. Objectives: The purpose of this study was
Squire, Iain
core   +1 more source

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9633-9643, October 2026.
ABSTRACT Aims Evidence regarding the efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in monogenic diabetes is limited. We evaluated real‐world metabolic, renal, and safety outcomes of SGLT2i therapy in adults with monogenic diabetes.
Estelle Audrain   +15 more
wiley   +1 more source

Myocardial Histopathology-Based Heart Failure Phenotyping. [PDF]

open access: yesJACC Heart Fail
Tersalvi G   +9 more
europepmc   +1 more source

LVEF-based phenotyping in very old adults hospitalised for heart failure: cardiological discrimination, shared geriatric burden, and treatment gaps. [PDF]

open access: yesFront Cardiovasc Med
Esser R   +10 more
europepmc   +1 more source

Heart Failure Phenotypes Across Age Groups in the Danish Administrative Registers. [PDF]

open access: yesClin Epidemiol
Garred CH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy